The imperative is to fully understand the implications of any change

August 8, 2025 Latest News BioPharma Comment

This is a preview of subscriber content

Subscribe now to continue reading.

How will a change that has been inconsistently described during the HTA Review process and in its official documents impact this critical public health program over time, and what will it mean for patient access to medicines? …

Subscribe now to continue reading.

Latest Video

Mark Butler asking questions about Trump's 'Most Favored Nation' pricing push
August 27, 2025 - Latest News
'Patients can’t wait – swift action and access are the only possible moves from here'
August 26, 2025 - Latest News
Government and Coalition combine to defeat Moderna agreement motion
August 26, 2025 - Latest News
Australians are rapidly increasing their adoption of AI, including for healthcare
August 26, 2025 - Latest News
Bristol Myers Squibb launches cancer resources for First Nations Australians
August 27, 2025 - Latest News

The imperative is to fully understand the implications of any change

This is a preview of subscriber content

Latest Video

Most Read

Mark Butler asking questions about Trump's 'Most Favored Nation' pricing push

'Patients can’t wait – swift action and access are the only possible moves from here'

Government and Coalition combine to defeat Moderna agreement motion

Australians are rapidly increasing their adoption of AI, including for healthcare

Bristol Myers Squibb launches cancer resources for First Nations Australians

New Stories

Coalition turns debate on cheaper medicines Bill to HTA reform delays

Pharmacy Guild showcases more accessible healthcare for women

Sandoz pushes for biosimilar reform while building a great workplace

Cartherics secures Chinese patent to boost immune cell function in solid tumours

NeuroScientific’s StemSmart MSC therapy shows promise in kidney transplantation

Starpharma advances dendrimer platform with clinical, commercial, and strategic progress

Biome achieves breakthrough year with first profit and rapid global expansion

Sign In

The imperative is to fully understand the implications of any change

This is a preview of subscriber content

Latest Video

Most Read

Mark Butler asking questions about Trump's 'Most Favored Nation' pricing push

'Patients can’t wait – swift action and access are the only possible moves from here'

Government and Coalition combine to defeat Moderna agreement motion

Australians are rapidly increasing their adoption of AI, including for healthcare

Bristol Myers Squibb launches cancer resources for First Nations Australians

Follow Us

New Stories

Coalition turns debate on cheaper medicines Bill to HTA reform delays

Pharmacy Guild showcases more accessible healthcare for women

Sandoz pushes for biosimilar reform while building a great workplace

Cartherics secures Chinese patent to boost immune cell function in solid tumours

NeuroScientific’s StemSmart MSC therapy shows promise in kidney transplantation

Starpharma advances dendrimer platform with clinical, commercial, and strategic progress

Biome achieves breakthrough year with first profit and rapid global expansion